This analysis is based on interviews with health biotech experts from around the world. The report describes the category of health technologies known as “biologics” and presents trends in the global biologics market. It unpacks the strategies used by different countries to attract investments and technology transfer, resulting in the emergence of biologics centers of excellence for R&D and manufacturing.